We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ananda Developments Plc | AQSE:ANA | Aquis Stock Exchange | Ordinary Share | GB00BDQPXQ60 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.425 | 0.40 | 0.45 | 0.425 | 0.415 | 0.425 | 275,000 | 15:29:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Notice of General Meeting
The Directors of Ananda Developments PLC are pleased to announce that, further to the announcement of 9 September 2024 regarding the Fundraise and Proposed Debt Capitalisation, the Company is today posting a Notice of Meeting to Shareholders convening a General Meeting ("GM") of the Company to approve the Proposed Debt Capitalisation for 2.00 p.m. on 8th October 2024.
The GM is to be held at the offices of Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London EC3V 0HR, at which the following resolutions will be proposed:
Resolution 1 - Authority to allot shares; and
Resolution 2 - Disapplication of pre-emption rights.The passing of Resolution 1 will require the approval of Shareholders by way of a simple majority. Resolution 2 will require the approval of a majority of not less than 75% of the votes cast by those entitled to vote.
Full details of the Notice of Meeting and the Proxy card will be available on the Company's website at: https://anandadevelopments.com/publications/
Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 10.30a.m. on 9 September 2024.
To stay up to date with the latest developments at Ananda, we encourage you to follow and join our social media channels which are:
· Register at our Investor Hub: https://investors.anandadevelopments.com/s/a66906
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
For more information please contact:
InvestorHub Engage with us directly at Ananda Developments Investor Hub
|
Sign up at https://investors.anandadevelopments.com/s/a66906
|
ANANDA DEVELOPMENTS PLC Chief Executive Officer Melissa Sturgess
Jeremy Sturgess-Smith
|
+44 (0)7463 686 497 ir@anandadevelopments.com |
SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Caroline Rowe |
+44 (0)20 3470 0470 |
Corporate Broking Abigail Wayne Rob Rees
|
|
Yellow Jersey PR Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512
|
About Ananda Developments
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions
For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.
https://investors.anandadevelopments.com/link/7Pl43P
1 Year Ananda Developments Chart |
1 Month Ananda Developments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions